The high cost of prescription drugs and the potential for long-term use have raised concerns about their financial impact on the healthcare system. However, new research from NYU Stern School of Business suggests that there may be a way to save money in the long run if discounts are negotiated.
Michael Dickstein, a professor at NYU Stern, conducted a study comparing the costs of prescription drugs with the savings from improved health outcomes. He found that with a 50 percent discount on the cost of the drugs, the healthcare system could actually save money as a result of these treatments.
The long-term effects of these drugs are still unknown, but this research provides hope that if insurers and payers negotiate lower prices, it could lead to significant cost savings in the future. It’s important to continue monitoring these developments and understanding their financial impact on the healthcare system as a whole.
